World Library  
Flag as Inappropriate
Email this Article

Sanguinarine

Article Id: WHEBN0004053506
Reproduction Date:

Title: Sanguinarine  
Author: World Heritage Encyclopedia
Language: English
Subject: Mouthwash, Thebaine, Glaucine, List of compounds with carbon number 20, Dihydrobenzophenanthridine oxidase
Collection:
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Sanguinarine

Sanguinarine
Systematic (IUPAC) name
13-Methyl-[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridinium
Clinical data
Legal status
?
Identifiers
CAS number  N
ATC code None
PubChem
ChemSpider  YesY
UNII  YesY
ChEBI  YesY
ChEMBL  YesY
Chemical data
Formula C20H14NO4 
Mol. mass 332.09
 N   

Sanguinarine is a toxic quaternary ammonium salt from the group of benzylisoquinoline alkaloids. It is extracted from some plants, including bloodroot (Sanguinaria canadensis), Mexican prickly poppy Argemone mexicana,[1] Chelidonium majus and Macleaya cordata. It is also found in the root, stem and leaves of the opium poppy but not in the capsule.

Contents

  • Toxicity 1
  • Medical study 2
  • Biosynthesis 3
  • See also 4
  • References 5

Toxicity

Sanguinarine is a toxin that kills animal cells through its action on the Na+-K+-ATPase transmembrane protein.[2] Epidemic dropsy is a disease that results from ingesting sanguinarine.[3]

If applied to the skin, sanguinarine kills cells and may destroy tissue. In turn, the bleeding wound may produce a massive scab, called an eschar. For this reason, sanguinarine is termed an escharotic.[4]

Medical study

Preliminary pre-clinical in vitro and in vivo studies have demonstrated that sanguinarine causes apoptosis in human cancer cells, and recommend study of sanguinarine as a potential cancer treatment.[5][6][7][8][9][10][11] A study conducted by the Case Western Reserve University in 2000 found that low doses of sanguinarine caused this apoptosis in cancerous human epidermoid carcinoma cells while little reaction from normal human skin cells was observed.[12] However, no products containing sanguinarine are currently approved by the FDA for the treatment of cancer; the FDA warns that unapproved bloodroot preparations are ineffective and dangerous.[13]

Biosynthesis

In plants, sanguinarine is synthesized from dihydrosanguinarine through the action of dihydrobenzophenanthridine oxidase.[14]

See also

  • Berberine, a plant based compound with similar chemical classification as sanguinarine

References

  1. ^ Santos, Alfredo C.; Adkilen, Pacifica (1932). "The Alkaloids of Argemone Mexicana". Journal of the American Chemical Society 54 (7): 2923–2924.  
  2. ^ Pitts, Barry J. R.; Meyerson, Laurence R. (1981). "Inhibition of Na,K-ATPase Activity and Ouabain Binding by Sanguinarine". Drug Development Research 1 (1): 43–49.  
  3. ^ Das, M; Khanna, S. K. (1997). "Clinicoepidemiological, Toxicological, and Safety Evaluation Studies on Argemone Oil". Critical Reviews in Toxicology 27 (3): 273–297.  
  4. ^ Cienki, J. J.; Zaret, L (2010). "An Internet Misadventure: Bloodroot Salve Toxicity". The Journal of Alternative and Complementary Medicine 16 (10): 1125–1127.  
  5. ^ Aburai, N; Yoshida, M; Ohnishi, M; Kimura, K (March 2010). "Sanguinarine as a potent and specific inhibitor of protein phosphatase 2C in vitro and induces apoptosis via phosphorylation of p38 in HL60 cells". Bioscience Biotechnology and Biochemistry 74 (3): 548–52.  
  6. ^ Weerasinghe, P; Hallock, S; Brown, R. E.; Loose, D. S.; Buja, L. M. (May 2012). "A model for cardiomyocyte cell death: Insights into mechanisms of oncosis". Experimental and Molecular Pathology 94 (1): 289–300.  
  7. ^ Adhami, V. M.; Aziz, M. H.; Mukhtar, H; Ahmad, N (August 2003). "Activation of prodeath Bcl-2 family proteins and mitochondrial apoptosis pathway by sanguinarine in immortalized human HaCaT keratinocytes". Clinical Cancer Research 9 (8): 3176–82.  
  8. ^ Sun, M; Lou, W; Chun, J. Y.; Cho, D. S.; Nadiminty, N; Evans, C. P.; Chen, J; Yue, J; Zhou, Q; Gao, A. C. (March 2010). "Sanguinarine suppresses prostate tumor growth and inhibits survivin expression". Genes & Cancer 1 (3): 283–92.  
  9. ^ Holy, Jon; Lamont, Genelle; Perkins, Edward (March 2010). "Disruption of nucleocytoplasmic trafficking of cyclin D1 and topoisomerase II by sanguinarine". BMC Cell Biology 7 (13): 283–92.  
  10. ^ Malikova, J; Zdarilova, A; Hlobilkova, A (2006). "Effects of Sanguinarine and Chelerytherythrine on the Cell Cycle and Apoptosis". Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150 (1): 5–12.  
  11. ^ Pica, F; Balestrieri, E; Serafino, A; Sorrentino, R; Gaziano, R; Moroni, G; Moroni, N; Palmieri, G; Mattei, M; Garaci, E; Sinibaldi-Vallebona, P (March 2010). "Antitumor effects of the benzophenanthridine alkaloid sanguinarine in a rat syngeneic model of colorectal cancer". Genes & Cancer 1 (3): 283–92.  
  12. ^ Ahmad, N; Gupta, S; Husain, M. M.; Heiskanen, K. M.; Mukhtar, H (April 2000). "Differential Antiproliferative and Apoptotic Response of Sanguinarine for Cancer Cells versus Normal Cells". Clinical Cancer Research 6 (4): 1524–8.  
  13. ^ "187 Fake Cancer "Cures" Consumers Should Avoid".  
  14. ^ "Chelirubine, Macarpine, and Sanguinarine Biosynthesis". Recommendations on Biochemical & Organic Nomenclature, Symbols & Terminology etc.. International Union of Biochemistry and Molecular Biology. 
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 



Copyright © World Library Foundation. All rights reserved. eBooks from World eBook Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.